| The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation S Kant, SP Menez, M Hanouneh, DM Fine, DC Crews, DC Brennan, ... BMC nephrology 21, 1-13, 2020 | 123 | 2020 |
| Sunlight exposure and development of rickets in Indian toddlers VH Ekbote, AV Khadilkar, MZ Mughal, N Hanumante, N Sanwalka, ... The Indian Journal of Pediatrics 77, 61-65, 2010 | 77 | 2010 |
| Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis Q Jin, S Kant, J Alhariri, D Geetha Journal of Community Hospital Internal Medicine Perspectives 8 (6), 339-344, 2018 | 61 | 2018 |
| Advances in understanding of pathogenesis and treatment of immune-mediated kidney disease: A review S Kant, A Kronbichler, P Sharma, D Geetha American Journal of Kidney Diseases 79 (4), 582-600, 2022 | 45 | 2022 |
| BK virus nephropathy in kidney transplantation: a state-of-the-art review S Kant, A Dasgupta, S Bagnasco, DC Brennan Viruses 14 (8), 1616, 2022 | 35 | 2022 |
| Donor-derived cell-free DNA and the prediction of BK virus-associated nephropathy S Kant, J Bromberg, M Haas, D Brennan Transplantation Direct 6 (11), e622, 2020 | 33 | 2020 |
| The impact of COVID-19 pandemic on patients with ANCA associated vasculitis S Kant, A Morris, S Ravi, L Floyd, E Gapud, B Antichos, A Dhaygude, ... Journal of Nephrology 34, 185-190, 2021 | 29 | 2021 |
| Combining donor-derived cell-free DNA fraction and quantity to detect kidney transplant rejection using molecular diagnoses and histology as confirmation PF Halloran, J Reeve, KS Madill-Thomsen, N Kaur, E Ahmed, C Cantos, ... Transplantation 106 (12), 2435-2442, 2022 | 22 | 2022 |
| Therapeutic advances in Fabry disease: the future awaits S Kant, MG Atta Biomedicine & Pharmacotherapy 131, 110779, 2020 | 22 | 2020 |
| Outcomes of kidney transplantation in Alport syndrome compared with other forms of renal disease YP Kelly, A Patil, L Wallis, S Murray, S Kant, MA Kaballo, L Casserly, ... Renal failure 39 (1), 290-293, 2017 | 21 | 2017 |
| Donor derived cell free DNA in kidney transplantation: the circa 2020–2021 update S Kant, DC Brennan Transplant International 35, 10448, 2022 | 20 | 2022 |
| Timing of COVID-19 vaccine in the setting of anti-CD20 therapy: a primer for nephrologists S Kant, A Kronbichler, A Salas, A Bruchfeld, D Geetha Kidney international reports 6 (5), 1197-1199, 2021 | 20 | 2021 |
| Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al CM Connolly, D Koenig, SN Ravi, A Azar, S Kant, M Dalal, J Duchen, ... Annals of the rheumatic diseases 80 (10), e164-e164, 2021 | 18 | 2021 |
| Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome–a single center experience S Kant, A Bhalla, S Alasfar, N Alachkar BMC nephrology 21, 1-6, 2020 | 17 | 2020 |
| Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis S Kant, A Azar, D Geetha Kidney international 101 (2), 414-415, 2022 | 14 | 2022 |
| Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis S Kant, D Geetha Kidney international 100 (5), 1124-1127, 2021 | 13 | 2021 |
| Characteristics and outcomes of COVID-19 in patients with antineutrophil cytoplasmic antibody–associated vasculitis S Kant, G Raman, P Damera, B Antiochos, P Seo, D Geetha Kidney International Reports 6 (3), 806-809, 2021 | 13 | 2021 |
| Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes VS Katikineni, S Kant, EJ Gapud, B Antiochos, RL Manno, M Phillips, ... Clinical rheumatology 38, 2195-2199, 2019 | 11 | 2019 |
| ANCA-associated vasculitis in scleroderma: a renal perspective S Kant, AA Shah, LK Hummers, FM Wigley, D Geetha Clinical nephrology 90 (6), 413, 2018 | 11 | 2018 |
| Renal transplantation in anti-neutrophil cytoplasmic antibody vasculitis D Geetha, S Kant Expert review of clinical immunology 14 (3), 235-240, 2018 | 11 | 2018 |
Daniel C BrennanJohns Hopkins Medical Institute在 jhmi.edu 的电子邮件经过验证
